PT93525A - Processo para a preparacao de polipeptideo pe40 modificado - Google Patents
Processo para a preparacao de polipeptideo pe40 modificadoInfo
- Publication number
- PT93525A PT93525A PT93525A PT9352590A PT93525A PT 93525 A PT93525 A PT 93525A PT 93525 A PT93525 A PT 93525A PT 9352590 A PT9352590 A PT 9352590A PT 93525 A PT93525 A PT 93525A
- Authority
- PT
- Portugal
- Prior art keywords
- polipeptideo
- modified
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32721489A | 1989-03-22 | 1989-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT93525A true PT93525A (pt) | 1990-11-07 |
PT93525B PT93525B (pt) | 1996-08-30 |
Family
ID=23275618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93525A PT93525B (pt) | 1989-03-22 | 1990-03-21 | Processo para a preparacao de polipeptideo pe40 modificado |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0389043A1 (pt) |
JP (1) | JPH0798839B2 (pt) |
KR (1) | KR0168047B1 (pt) |
CA (1) | CA2012732C (pt) |
FI (1) | FI901420A0 (pt) |
IL (1) | IL93723A (pt) |
NO (1) | NO901315L (pt) |
NZ (1) | NZ232900A (pt) |
PT (1) | PT93525B (pt) |
ZA (1) | ZA902171B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98528A0 (en) * | 1990-06-21 | 1992-07-15 | Merck & Co Inc | Pharmaceutical compositions containing hybrid for killing bladder cancer cells |
DE19735105A1 (de) * | 1997-08-13 | 1999-03-04 | Univ Albert Ludwigs Freiburg | Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL90047A (en) * | 1982-10-19 | 1992-12-01 | Cetus Oncology Corp | Cysteine-depleted biologically active muteins other than interferon - ' |
US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
WO1987002987A1 (en) * | 1985-11-13 | 1987-05-21 | Murphy John R | Cys codon-modified dna |
US4892827A (en) * | 1986-09-24 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
-
1990
- 1990-03-13 NZ NZ232900A patent/NZ232900A/xx unknown
- 1990-03-13 IL IL9372390A patent/IL93723A/xx active IP Right Grant
- 1990-03-15 EP EP90200613A patent/EP0389043A1/en not_active Ceased
- 1990-03-21 CA CA002012732A patent/CA2012732C/en not_active Expired - Fee Related
- 1990-03-21 FI FI901420A patent/FI901420A0/fi not_active Application Discontinuation
- 1990-03-21 PT PT93525A patent/PT93525B/pt not_active IP Right Cessation
- 1990-03-21 ZA ZA902171A patent/ZA902171B/xx unknown
- 1990-03-21 KR KR1019900003802A patent/KR0168047B1/ko not_active IP Right Cessation
- 1990-03-21 NO NO90901315A patent/NO901315L/no unknown
- 1990-03-22 JP JP2069889A patent/JPH0798839B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2012732C (en) | 1999-09-14 |
NO901315D0 (no) | 1990-03-21 |
JPH0335793A (ja) | 1991-02-15 |
FI901420A0 (fi) | 1990-03-21 |
IL93723A (en) | 1997-02-18 |
PT93525B (pt) | 1996-08-30 |
ZA902171B (en) | 1990-12-28 |
EP0389043A1 (en) | 1990-09-26 |
CA2012732A1 (en) | 1990-09-22 |
IL93723A0 (en) | 1990-12-23 |
NZ232900A (en) | 1993-08-26 |
JPH0798839B2 (ja) | 1995-10-25 |
KR900014598A (ko) | 1990-10-24 |
KR0168047B1 (ko) | 1999-01-15 |
NO901315L (no) | 1990-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT97433A (pt) | Processo para a preparacao de sacarose-6-ester | |
PT94059A (pt) | Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas | |
PT93785A (pt) | Processo para a preparacao de derivados de 3-substituido-2-oxindole | |
PT93452A (pt) | Processo para a preparacao de uma pastilha de colestiramina | |
BR8802484A (pt) | Processo para a preparacao de isocianatos | |
BR9003345A (pt) | Processo para a preparacao de 1,1,1,2-tetrafluoretano | |
PT90293A (pt) | Processo para a preparacao de macrolidos | |
PT91895A (pt) | Processo para a preparacao de 9h-purinas substituidas | |
PT92786A (pt) | Processo para a preparacao de compostos de tiazol | |
PT90854A (pt) | Processo para a preparacao de 1-aril-2-naftoilaminas | |
BR8906327A (pt) | Processo para a preparacao de organoclorossilanos | |
PT92638A (pt) | Processo para a preparacao de poliazamacrociclos mono-n-alquilados | |
BR9001503A (pt) | Processo para a preparacao de alquil-halogenossilanos | |
PT93629A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
PT89039A (pt) | Processo para a preparacao de l-ramnose | |
BR8803678A (pt) | Processo para a preparacao de polieteramidas | |
PT89056A (pt) | Processo para a preparacao de hidroxilaminas substituidas | |
PT96033A (pt) | Processo para a preparacao de flocos | |
PT97828A (pt) | Processo para a preparacao de fenil-triazinas | |
BR8903367A (pt) | Processo para a preparacao de organoclorossilanos | |
PT93736A (pt) | Processo para a preparacao de n,n'-ditrimetoxi-benzoil-piperazinas 2- substituidas | |
BR8806351A (pt) | Processo para a preparacao de fenil-ureias | |
PT94890A (pt) | Processo para a preparacao de compostos azofenilicos | |
BR8902030A (pt) | Processo para a preparacao de n-fosfonometilglicina | |
PT93631A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19960502 |
|
MM3A | Annulment or lapse |
Effective date: 20041102 |